Bongkrekic Acid induces Selective Cytotoxicity in Tumor Cells, revealed by CCK-8

DOI HANDLE Web Site 3 Citations Open Access
  • Kano Arihiro
    Institute for Materials Chemistry and Engineering, Kyusuh University
  • Kamita Moses Kibunja
    Interdisciplinary Graduate School of Engineering Sciences, Kyushu University
  • Iwasaki Takuma
    Interdisciplinary Graduate School of Engineering Sciences, Kyushu University
  • Shindo Mitsuru
    Institute for Materials Chemistry and Engineering, Kyushu University

Search this article

Abstract

Bongkrekic acid (BKA) is shown to inhibit adenine nucleotide translocator in the mitochondrial inner membrane, which is bifunctional and facilitates ATP/ADP exchange and permeability transition pore opening in mitochondria. We demonstrate that BKA reduces the viability of tumor cells depending on the cell number in the culture. This reduction was first demonstrated by Cell Counting Kit-8 (CCK-8), which indicates cellular viabilities based on the reduction of a formazan dye by cellular NADH. Reduced viability was not seen in normal cells. The glycolysis inhibitor 2-deoxyglucose enhanced the effect of BKA. BKA is thought to work as a mitochondrial inhibitor; however, its action is different from mitochondrial uncouplers. We further demonstrate that BKA suppresses autophagy induction, directing cells to death in nutrient-depleted conditions. Together these data indicate that BKA is a new type of mitochondrial inhibitor that does not disrupt the mitochondrial membrane and that is thus used together with a glycolysis inhibitor as an anticancer agent.

Journal

  • Evergreen

    Evergreen 4 (2/3), 23-27, 2017-09

    Transdisciplinary Research and Education Center for Green Technologies, Kyushu University

Citations (3)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top